Haya Therapeutics’ CHF 18 Million Seed Round

VISCHER advised Haya Therapeutics SA on all legal issues related to the financing round.HAYA Therapeutics SA, a company developing precision medicines that target tissue and cell-specific…

This content is for members only.
Login to Read More Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for members only.
Login to Read More Join Now